Article Details
Retrieved on: 2021-02-03 12:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(NASDAQ: KYMR), a biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader medicines, ...
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here